Barclays’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.6M Buy
74,029
+25,648
+53% +$553K ﹤0.01% 2383
2025
Q1
$1.11M Sell
48,381
-17,754
-27% -$405K ﹤0.01% 2389
2024
Q4
$1.72M Buy
66,135
+1,712
+3% +$44.4K ﹤0.01% 2300
2024
Q3
$1.61M Buy
64,423
+10,803
+20% +$270K ﹤0.01% 2335
2024
Q2
$1.15M Buy
53,620
+5,566
+12% +$119K ﹤0.01% 2042
2024
Q1
$892K Sell
48,054
-47,034
-49% -$873K ﹤0.01% 2487
2023
Q4
$1.55M Buy
95,088
+38,120
+67% +$619K ﹤0.01% 2323
2023
Q3
$787K Buy
56,968
+38,311
+205% +$529K ﹤0.01% 2255
2023
Q2
$412K Buy
18,657
+1,197
+7% +$26.4K ﹤0.01% 2722
2023
Q1
$380K Buy
17,460
+1,050
+6% +$22.9K ﹤0.01% 2817
2022
Q4
$299K Buy
16,410
+7,593
+86% +$138K ﹤0.01% 2893
2022
Q3
$201K Sell
8,817
-851
-9% -$19.4K ﹤0.01% 3086
2022
Q2
$133K Sell
9,668
-11,130
-54% -$153K ﹤0.01% 3345
2022
Q1
$472K Buy
20,798
+5,495
+36% +$125K ﹤0.01% 2845
2021
Q4
$570K Sell
15,303
-17,626
-54% -$657K ﹤0.01% 2475
2021
Q3
$1.39M Buy
32,929
+29,840
+966% +$1.26M ﹤0.01% 2066
2021
Q2
$137K Sell
3,089
-14,431
-82% -$640K ﹤0.01% 3033
2021
Q1
$630K Buy
17,520
+12,981
+286% +$467K ﹤0.01% 2547
2020
Q4
$181K Sell
4,539
-1,755
-28% -$70K ﹤0.01% 2737
2020
Q3
$182K Buy
6,294
+2,276
+57% +$65.8K ﹤0.01% 2784
2020
Q2
$66K Buy
4,018
+1,577
+65% +$25.9K ﹤0.01% 3296
2020
Q1
$23K Sell
2,441
-4,819
-66% -$45.4K ﹤0.01% 3350
2019
Q4
$117K Buy
7,260
+401
+6% +$6.46K ﹤0.01% 3398
2019
Q3
$114K Sell
6,859
-3,791
-36% -$63K ﹤0.01% 3330
2019
Q2
$181K Sell
10,650
-34,463
-76% -$586K ﹤0.01% 3259
2019
Q1
$807K Sell
45,113
-27,787
-38% -$497K ﹤0.01% 2307
2018
Q4
$877K Buy
72,900
+72,500
+18,125% +$872K ﹤0.01% 1906
2018
Q3
$7K Buy
+400
New +$7K ﹤0.01% 4037